DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Pistrosch F, Passauer J, Fischer S, Fuecker K, Hanefeld M, Gross P.
In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control.
Diabetes Care 2004; 27: 484-490
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.